1. Home
  2. CNXC vs NKTR Comparison

CNXC vs NKTR Comparison

Compare CNXC & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concentrix Corporation

CNXC

Concentrix Corporation

HOLD

Current Price

$26.46

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$67.84

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNXC
NKTR
Founded
1991
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
CNXC
NKTR
Price
$26.46
$67.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$54.80
$130.00
AVG Volume (30 Days)
1.6M
745.4K
Earning Date
03-24-2026
03-12-2026
Dividend Yield
5.45%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,825,771,000.00
$307,711,000.00
Revenue This Year
$5.17
N/A
Revenue Next Year
$2.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
86.00
52 Week Low
$24.27
$0.43
52 Week High
$62.14
$77.97

Technical Indicators

Market Signals
Indicator
CNXC
NKTR
Relative Strength Index (RSI) 38.32 49.11
Support Level N/A $64.50
Resistance Level $34.64 $75.96
Average True Range (ATR) 2.15 4.02
MACD -0.47 -1.23
Stochastic Oscillator 23.56 6.48

Price Performance

Historical Comparison
CNXC
NKTR

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Share on Social Networks: